CLASS 4 CAUTION IN USE - SYRENIRING 0.12MG/0.015MG 24 HR

Crescent Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the below batches is missing important safety relevant text changes

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-crescent-pharma-ltd-syreniring-0-120-mg-0-015-mg-per-24-hours-vaginal-delivery-system-el-20-a-36?utm_medium=email&utm_campaign=govuk-notifications&utm_source=8b7c3acf-aee7-4d91-8b27-85a8e19f72c8&utm_content=immediately               

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will  be required to follow the instructions as per the drug alert.

This is a caution in use only we are not accepting stock returns.

For more information or medical information queries, please contact: Crescent Pharma Ltd. Medical Information Department on +00351 214643225, via email on tiago.barca@pharsolution.com or +44 (0) 1256 772740..

If you have any questions, then please contact your local Service Centre Customer Services team.